Hypertension in the African American population: A succinct look at its epidemiology, pathogenesis, and therapy

Luis M Ortega1, Emad Sedki1, Ali Nayer2

  • 1Division of Nephrology and Hypertension. Allegheny General Hospital/Temple University School of Medicine. Pittsburgh, Pennsylvania (Estados Unidos).

Insights

Arterial hypertension is common in Black Americans, causing significant cardiovascular and kidney damage. Effective treatment requires lifestyle changes and antihypertensive medication, though the best drug choice remains undetermined.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Arterial hypertension disproportionately affects the Black population in the United States.
  • Hypertension is a major risk factor for cardiovascular disease and kidney damage.
  • Complex pathogenesis involves obesity, salt sensitivity, and renin-angiotensin-aldosterone system activation.

Purpose of the Study:

  • To review the challenges and recommendations for managing arterial hypertension in Black Americans.
  • To highlight the need for tailored therapeutic strategies.

Main Methods:

  • Literature review of existing studies and guidelines on hypertension in Black populations.
  • Analysis of contributing factors to hypertension pathogenesis.
  • Evaluation of current treatment recommendations.

Main Results:

  • The International Society of Hypertension in Blacks recommends dietary intervention for systolic/diastolic blood pressure >115/75 mmHg.
  • Target blood pressure should be maintained below 135/85 mmHg with appropriate antihypertensive medication.
  • The optimal antihypertensive drug for this demographic is not yet established.

Conclusions:

  • Management of arterial hypertension in Black Americans requires a multifaceted approach.
  • Combined dietary interventions and antihypertensive pharmacotherapy are essential.
  • Further research is needed to determine the most effective antihypertensive agents for this population.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
845
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
723
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K